logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
8/17/2018 7:01:49 AM Regeneron Pharma: FDA Approves EYLEA Injection SBLA In Wet Age-related Macular Degeneration
8/16/2018 7:02:28 AM Regeneron, Teva Unveil Positive Topline Phase 3 Fasinumab Results In Patients With Chronic Pain From OA Of Knee/Hip
8/13/2018 7:03:26 AM Regeneron Provides Regulatory Update On EYLEA Injection; Expects To Get A Final FDA Action Within About Two Months
8/6/2018 6:32:25 AM Bluebird Bio, Regeneron Partner To Apply Technology Platforms To Develop Novel Cell Therapies For Cancer
8/2/2018 6:32:16 AM Regeneron Q2 GAAP EPS 44% To $4.82; Non-GAAP EPS Up 31% To $5.45
6/6/2018 7:02:00 AM Regeneron And Zoetis Announce Five-year Collaboration To Research Antibody Therapies For Use In Animal Health